Coronavirus

Intranasal vaccine platform may allow for an immune response to be induced more precisely to provide the best possible protection from coronavirus disease 2019.

Pharmacy Times® interviewed Clayton Edwards, RPh, MBA, chief operating officer of AllianceRx Walgreens Prime, on the importance of disaster preparation in pharmacies during hurricane season in the midst of a pandemic.

As public trust in vaccines has fallen, it’s up to pharmacists to combat misinformation.

Pharmacists should be vocal in objecting to unproven therapies for COVID-19 being widely used primarily based on wishful thinking.

As patients return to their routines of returning to pharmacies and the inevitable discussions about COVID-19 begin, it may be a good time to discuss the range of tests that the CDC recommends.

National Association of Chain Drug Stores joins with 20 other groups in asking Congress to take action that includes designating pharmacists as providers under Medicare.

New research indicates a need to understand the mental health impacts of the coronavirus disease 2019 pandemic.

Helath care workers report higher levels of stress, anxiety, and fatigue, as well as reduced feelings of control over their lives, as a result of COVID-19.

Cancer care providers have increasingly been using biosimilars on a case-by-case basis with patients.

Gilead Sciences is increasing the global supply of the investigational drug remdesivir in preparation for demand in fighting COVID-19.

Top news of the week from Pharmacy Times®.

New testing method may improve the speed, handling time, and cost of laboratory tests for coronavirus disease 2019.

In a world increasingly influenced by technology, there is ample opportunity to leverage automation within pharmacies that can not only improve operations, but support patient wellness.

Study suggests the ability of younger children to transmit COVID-19 may have been under-recognized because of the rapid, long-term closure of schools and daycares during the pandemic.

Study finds that health care systems need to develop additional strategies to protect workers from COVID-19.

Emergency department visits dropped significantly in March as the public responded to shelter-in-place messages as a result of the COVID-19 pandemic, according to a new study from researchers at Yale University and the Mayo Clinic.

A temporary public policy change and insurers' expanded benefits have allowed the growth of telehealth services during the COVID-19 pandemic.

Pharmacy Times spoke with Jessica Langley, MS, executive director of education and advocacy of NHA, about how the pandemic has changed the pharmacy technician industry and advice for future pharmacy technician opportunities.

Study shows an increase in anxiety and depression among college students since the start of the coronavirus disease 2019 pandemic.

Furthermore, the investigators noted that choline levels high enough to protect the fetus often require dietary supplementation, which offers a chance for pharmacists to provide counseling.

This Pharmacy Times® Webcast discusses a number of topics pertaining to the pharmacists’ role in immunization practices, including the precautions and safety equipment necessary amidst the COVID-19 pandemic, pharmacy automation and operations, and best practices to navigate patient care.

National Association of Chain Drug Stores (NACDS) President and CEO Steven C. Anderson issued a statement on July 31 regarding the nation’s preparations for the eventual deployment of COVID-19 vaccines.

Pharmacists offer a variety of services that can help patients to manage diabetes and other chronic conditions, especially during the COVID-19 pandemic.

There is no perfect moment to timestamp the accelerated, massive movement toward finding and distributing the first vaccine candidates for the coronavirus 2019 pandemic.

Providers help transition patients home from doctors’ offices and hospitals during pandemic.

A virtual event was hosted on July 28 by the Economic Club of Washington, DC, on how to immunize Americans as fast as possible upon the release of a COVID-19 vaccine.

Although the rapid expansion of telehealth has been an essential part of keeping patients safe during the COVID-19 pandemic, the potential long-term effects of this expansion have not been fully understood.

An expert panel of world-renowned professionals will discuss the latest details on the rapid advances in vaccine development and what they mean to clinicians on the front line.

As clinicians, we must first understand the unique challenges that a patient is facing and then tailor our support to address their specific needs.

As legislators debate the next stimulus package, pharmacists are expressing dismay that the current language does not include designating pharmacists as providers under Medicare Part B for COVID-19 testing and immunization.